Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
26.3K
-
Shares change
-
0
-
Total reported value, excl. options
-
$74.6K
-
Price
-
$2.84
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q4 2023
1 filings reported holding HUMA - Humacyte, Inc. - COM as of Q4 2023.
Humacyte, Inc. - COM (HUMA) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.3K shares
.
Largest 10 shareholders include BlackRock Inc. (4.9M shares), VANGUARD GROUP INC (3.12M shares), GEODE CAPITAL MANAGEMENT, LLC (1.33M shares), MILLENNIUM MANAGEMENT LLC (1.3M shares), STATE STREET CORP (1.15M shares), Prescott General Partners LLC (568K shares), NORTHERN TRUST CORP (565K shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (491K shares), GSA CAPITAL PARTNERS LLP (437K shares), and LPL Financial LLC (368K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.